Cancer risk in patients with inflammatory bowel disease: a population-based study - PubMed (original) (raw)
Cancer risk in patients with inflammatory bowel disease: a population-based study
C N Bernstein et al. Cancer. 2001.
Abstract
Background: The objective of the current study was to determine the incidence of cancer among persons with inflammatory bowel disease (IBD) and to compare these incidence rates with those of the non-IBD population using population-based data from the administrative claims data of Manitoba's universal provincial insurance plan (Manitoba Health).
Methods: IBD patients were matched 1:10 to randomly selected members of the population without IBD based on year, age, gender, and postal area of residence. The incidence of cancer was determined by linking records from the IBD and non-IBD cohorts with the comprehensive Cancer Care Manitoba registry. Incidence rates and rate ratios (IRR) were calculated based on person-years of follow-up (Crohn's disease = 21,340 person-years and ulcerative colitis [UC] = 19,665 person-years) for 1984-1997.
Results: There was an increased IRR of colon carcinoma for both Crohn disease patients (2.64; 95% confidence interval [95% CI], 1.69-4.12) and UC patients (2.75; 95% CI, 1.91-3.97). There was an increased IRR of rectal carcinoma only among patients with UC (1.90; 95% CI, 1.05-3.43) and an increased IRR of carcinoma of the small intestine only in Crohn disease patients (17.4; 95% CI, 4.16-72.9). An increased IRR of extraintestinal tumors was observed only for the liver and biliary tract in both Crohn disease patients (5.22; 95% CI, 0.96-28.5) and UC patients (3.96; 95% CI, 1.05-14.9). There was an increased IRR of lymphoma for males with Crohn disease only (3.63; 95% CI, 1.53-8.62), and this finding did not appear to be related to use of immunomodulatory therapy. Compared with controls, Crohn's disease was associated with an increased risk of cancer overall, but UC was not.
Conclusions: There appear to be similar increased risks for developing colon carcinoma and hepatobiliary carcinoma among patients with Crohn disease and UC. There is an increased risk of developing rectal carcinoma in UC patients, an increased risk of developing carcinoma of the small bowel in Crohn disease patients, and an increased risk of developing lymphoma among males with Crohn disease.
Copyright 2001 American Cancer Society.
Similar articles
- Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C. Cheddani H, et al. Am J Gastroenterol. 2016 Oct;111(10):1428-1436. doi: 10.1038/ajg.2016.304. Epub 2016 Aug 2. Am J Gastroenterol. 2016. PMID: 27481308 - The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
Bernstein CN, Blanchard JF, Houston DS, Wajda A. Bernstein CN, et al. Thromb Haemost. 2001 Mar;85(3):430-4. Thromb Haemost. 2001. PMID: 11307809 - The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies.
Lo B, Zhao M, Vind I, Burisch J. Lo B, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1117-1138.e19. doi: 10.1016/j.cgh.2020.08.015. Epub 2020 Aug 13. Clin Gastroenterol Hepatol. 2021. PMID: 32801010 Review. - Familial risk of inflammatory bowel disease: a population-based cohort study 1977-2011.
Moller FT, Andersen V, Wohlfahrt J, Jess T. Moller FT, et al. Am J Gastroenterol. 2015 Apr;110(4):564-71. doi: 10.1038/ajg.2015.50. Epub 2015 Mar 24. Am J Gastroenterol. 2015. PMID: 25803400 - Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.
Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Pedersen N, et al. Am J Gastroenterol. 2010 Jul;105(7):1480-7. doi: 10.1038/ajg.2009.760. Epub 2010 Mar 23. Am J Gastroenterol. 2010. PMID: 20332773 Review.
Cited by
- Recent advances in bacteria-based platforms for inflammatory bowel diseases treatment.
Lu J, Shen X, Li H, Du J. Lu J, et al. Exploration (Beijing). 2024 Mar 5;4(5):20230142. doi: 10.1002/EXP.20230142. eCollection 2024 Oct. Exploration (Beijing). 2024. PMID: 39439496 Free PMC article. Review. - Incidence of intestinal & extra-intestinal cancers among individuals with Crohn's disease in northern India.
Sharma P, Putambekar V, Kumar P, Thomas DM, Vuyyuru SK, Kante B, Mundhra SK, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V. Sharma P, et al. Indian J Med Res. 2024 Jul;160(1):61-69. doi: 10.25259/ijmr_1722_23. Indian J Med Res. 2024. PMID: 39382506 Free PMC article. - Insights into renal and urological complications of inflammatory bowel disease.
Singh A, Khanna T, Mahendru D, Kahlon J, Kumar V, Sohal A, Yang J. Singh A, et al. World J Nephrol. 2024 Sep 25;13(3):96574. doi: 10.5527/wjn.v13.i3.96574. World J Nephrol. 2024. PMID: 39351187 Free PMC article. Review. - Gastrointestinal Malignancy: Genetic Implications to Clinical Applications.
Trembath HE, Yeh JJ, Lopez NE. Trembath HE, et al. Cancer Treat Res. 2024;192:305-418. doi: 10.1007/978-3-031-61238-1_15. Cancer Treat Res. 2024. PMID: 39212927 Review. - Possible poor prognosis in younger-onset Crohn's disease-associated anorectal cancer: A subanalysis of the Nationwide Japanese study.
Okita Y, Toiyama Y, Ikeuchi H, Uchino M, Futami K, Okamoto K, Noguchi T, Sugihara K, Ishihara S, Ajioka Y; from the Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon and Rectum. Okita Y, et al. Ann Gastroenterol Surg. 2024 Jan 27;8(4):620-630. doi: 10.1002/ags3.12773. eCollection 2024 Jul. Ann Gastroenterol Surg. 2024. PMID: 38957565 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources